Home/ Stocks/ SILO

Silo Pharma, Inc. Common Stock

SILO XNAS

$6.01 -0.17 (-2.91%) ▼ 15-min delayed

Open

N/A

High

N/A

Low

N/A

Volume

N/A

Market Cap

$6.64M

About Silo Pharma, Inc. Common Stock

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 3 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$18.0K	$-1,647,117	$-0.12
FY 2025	$72.1K	$-4,227,698	$-0.50
Q3 2025	$18.0K	$-1,110,438	$-0.12
Q1 2025	$18.0K	$-1,031,437	$-0.23

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 11, 2026

Calendar →

TickerDaily Coverage

Why Is Silo Pharma, Inc. Common Stock (SILO) Stock Up 35.1% Today?

Penny Stocks Marcus Rivera · Feb 24, 2026

Silo Pharma (SILO) stock ripped 35.1% higher to $0.2812 after announcing a strategic agreement with...

View All Coverage →

Get SILO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Silo Pharma, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.